<DOC>
	<DOCNO>NCT01125995</DOCNO>
	<brief_summary>The purpose study evaluate efficacy toxicity different timing concurrent chemoradiation treatment limit disease status Small-cell lung cancer .</brief_summary>
	<brief_title>Early Versus Late Concurrent Chemoradiation Limited Stage Small-cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<criteria>histologically confirm smallcell lung cancer limit disease status evaluable disease 18 year old ECOG performance status 0,1,2 expect survival time 12 week longer Adequate organ function evidence follow ; Absolute neutrophil count &gt; 1.5 x 109/L ; platelet &gt; 100 x 109/L ; total bilirubin ≤1.5 UNL ; AST and/or ALT &lt; 5 UNL ; creatinine clearance ≥ 50mL/min Written informed consent form 1 . Uncontrolled systemic illness DM , CHF , unstable angina , hypertension arrhythmia 2 . Patients active infection require antibiotic 3 . Pregnant nursing woman ( Women reproductive potential agree use effective contraceptive method ) 4 . Prior history malignancy within 5 year study entry except adequately treat basal cell squamous cell skin cancer situ cervical cancer , welltreated thyroid cancer 5. previous history chemotherapy radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>limited disease</keyword>
</DOC>